1. Are we ready to move away from nature? The rapamycin story

   • Monica Mita
   • Alain Mita

   Editorial 15 June 2011 Pages: 63 - 64

2. Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges

   • Laura Catena
   • Emilio Bajetta
   • Valentina Colonna

   Original Research 06 April 2011 Pages: 65 - 68

   

3. Clinical activity of mammalian target of rapamycin inhibitors in solid tumors

   • Yesid Alvarado
   • Monica M. Mita
   • Alain C. Mita

   Review 04 May 2011 Pages: 69 - 94

   

4. Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences

   • Hakan Cam
   • Peter J. Houghton

   Review 16 April 2011 Pages: 95 - 102

   

5. Targeting phosphatidylinositol 3 kinase (PI3K)-Akt beyond rapalogs

   • Shin Ogita
   • Patricia LoRusso

   Review 06 May 2011 Pages: 103 - 117

   

6. Predictive biomarkers for the activity of mammalian target of rapamycin (mTOR) inhibitors

   • Catherine Delbaldo
   • Sébastien Albert
   • Sandrine Faivre

   Review 28 April 2011 Pages: 119 - 124

   

7. Common toxicities of mammalian target of rapamycin inhibitors

   • Scott A. Soefje
   • Anand Karnad
   • Andrew J. Brenner

   Review 16 April 2011 Pages: 125 - 129